These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8310409)

  • 1. L-arginine stimulates host defenses in patients with breast cancer.
    Brittenden J; Park KG; Heys SD; Ross C; Ashby J; Ah-See Ak; Eremin O
    Surgery; 1994 Feb; 115(2):205-12. PubMed ID: 8310409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural cytotoxicity in breast cancer patients receiving neoadjuvant chemotherapy: effects of L-arginine supplementation.
    Brittenden J; Heys SD; Ross J; Park KG; Eremin O
    Eur J Surg Oncol; 1994 Aug; 20(4):467-72. PubMed ID: 8076711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary supplementation with L-arginine: modulation of tumour-infiltrating lymphocytes in patients with colorectal cancer.
    Heys SD; Segar A; Payne S; Bruce DM; Kernohan N; Eremin O
    Br J Surg; 1997 Feb; 84(2):238-41. PubMed ID: 9052446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
    McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
    Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
    Mills KC; Gross TG; Varney ML; Heimann DG; Reed EC; Kessinger A; Talmadge JE
    Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of intralymphatic interleukin-2. I. Cytotoxic and surface marker changes of peripheral blood lymphocytes.
    Shau H; Isacescu V; Ibayashi Y; Tokuda Y; Golub SH; Fahey JL; Sarna GP
    J Biol Response Mod; 1990 Feb; 9(1):71-80. PubMed ID: 2319261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human GM-CSF enhances T cell-mediated cytotoxic function after ABMT for hematological malignancies.
    Richard C; Alsar MJ; Calavia J; Bello-Fernandez C; Baro J; Loyola I; Rios R; Cuadrado MA; Gonzalez-Pardo C; Iriondo A
    Bone Marrow Transplant; 1993 Jun; 11(6):473-8. PubMed ID: 8334429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells.
    Naume B; Shalaby R; Lesslauer W; Espevik T
    J Immunol; 1991 May; 146(9):3045-8. PubMed ID: 1707931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of iron loading on peripheral blood lymphocyte subsets and on circulating cytokine levels in iron-depleted hemodialysis patients receiving erythropoietin.
    Tsouchnikas I; Tsilipakou M; Daniilidis M; Kyriazis G; Pasadakis P; Parapanissiou E; Vargemezis V; Tsakiris D
    Nephron Clin Pract; 2007; 107(3):c97-102. PubMed ID: 17890877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine stimulates lymphocyte immune response in healthy human beings.
    Barbul A; Sisto DA; Wasserkrug HL; Efron G
    Surgery; 1981 Aug; 90(2):244-51. PubMed ID: 7020137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer and lymphokine-activated killer activities in stomach cancer patients with special emphasis on the effect of 5-fluorouracil, adriamycin and mitomycin-C chemotherapy.
    Hong WS; Kim CM; Lee JO; Kang TW; Yun TK; Kim CY
    Jpn J Clin Oncol; 1990 Mar; 20(1):87-93. PubMed ID: 2108272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
    Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
    J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J; Broxmeyer HE
    Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.
    LeFever AV; Funahashi A
    Cancer Res; 1991 Oct; 51(20):5596-601. PubMed ID: 1655257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated endothelial cells resist lymphokine-activated killer cell-mediated injury. Possible role of induced cytokines in limiting capillary leak during IL-2 therapy.
    Mier JW; Brandon EP; Libby P; Janicka MW; Aronson FR
    J Immunol; 1989 Oct; 143(7):2407-14. PubMed ID: 2528594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
    Joshi SS; Bishop MR; Lynch JC; Tarantolo SR; Abhyankar S; Bierman PJ; Vose JM; Geller RB; McGuirk J; Foran J; Bociek RG; Hadi A; Day SD; Armitage JO; Kessinger A; Pavletic ZS
    Cytotherapy; 2003; 5(6):542-52. PubMed ID: 14660050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
    Gemlo BT; Palladino MA; Jaffe HS; Espevik TP; Rayner AA
    Cancer Res; 1988 Oct; 48(20):5864-7. PubMed ID: 3139285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of interferon-alpha and gamma on development of LAK activity from mononuclear cells in breast cancer patients.
    Kamamura Y; Takahashi K; Komaki K; Monden Y
    J Med Invest; 1998 Aug; 45(1-4):71-5. PubMed ID: 9864966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of the nitric oxide-synthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells.
    Cifone MG; Festuccia C; Cironi L; Cavallo G; Chessa MA; Pensa V; Tubaro E; Santoni A
    Cell Immunol; 1994 Aug; 157(1):181-94. PubMed ID: 7518750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.